News & Updates
Filter by Specialty:

Triple G agonist shows therapeutic potential in obesity
11 Sep 2023
Treatment with retatrutide, the novel agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors, leads to marked reductions in body weight in individuals with obesity, as shown in the results of a phase II trial.
Triple G agonist shows therapeutic potential in obesity
11 Sep 2023
Female sex protective against obesity-driven dysregulation of glucose metabolism
04 Sep 2023
byStephen Padilla
Insulin sensitivity and secretion differ by sex among Asians without diabetes, reveals a study, noting that female sex is protective on obesity-driven dysregulation of glucose metabolism.